Thank you for the submission of your research manuscript to EMBO reports. We have now received reports from the three referees that were asked to evaluate your study, which can be found at the end of this email.
As you will see, all three referees acknowledge the potential interest of the findings. However, all three referees have raised a number of concerns and suggestions to improve the manuscript or to strengthen the data and the conclusions drawn. In particular all points by referee #1 are important. Also most concerns of referees #2 and #3 need to be addressed. However, we feel that points 2 (actin changes), 9 (other residues than S128), 11 (CRISPR/Cas9) and 13 (YAP targets) of referee #2 and point 2 of referee #3 do not need to be addressed experimentally (however, if you can address these, it would certainly strengthen the manuscript further). Most importantly, proper quantifications and statistics should be provided where applicable throughout the manuscript! Given these constructive comments, we would like to invite you to revise your manuscript with the understanding that all referee concerns (as detailed in their reports) must be fully addressed in a complete point-by-point response. Acceptance of your manuscript will depend on a positive outcome of a second round of review. It is EMBO reports policy to allow a single round of revision only and acceptance or rejection of the manuscript will therefore depend on the completeness of your responses included in the next, final version of the manuscript.
REFEREE REPORTS ----------------------------------Referee #1:
Hong et al. report in this very interesting manuscript several points that are important for the broader Hippo signalling community. This manuscript is well-presented and the overall implications of the research findings have great potential. However, I think that this manuscript can benefit from some adjustments/extensions as outlined below. I firmly believe that by addressing these points this manuscript will be even more appreciated by the Hippo signalling community and the scientific community at large.
Main points:
1) Correct referencing on page 4:
On page 4 the authors state that: "... which is known to promote LATS kinase activity [28] ". I am very familiar with the review that is cited as reference 28, so I think that is quite inadequate to be cited in this context. Therefore, I strongly suggest to rather cite instead original publications such as: 2) Include statistical analyses to support all "significant" statements. The authors repeatedly state that they observed "significant" changes, which consequently should be backed up by the statistical evaluation of at least three independent experiments. Fortunately, this should be rather easy for Moon et al. to address, since they state in the Methods section (in the subsection "Statistical analysis") that: "Each experiment was repeated three times..." Therefore, please include a statistical analysis of the three independent experiments for: (i) Figure 1C (change of Lats1 kinase activity) (ii) Figure 2E (change of 14-3-3/YAP interaction) (iii) Figure 4D (S128-P in NLK null vs. wild-type cells) (iv) Figure 4F (change of 14-3-3/YAP interaction) -to match/complement Figure 2E 3) Expand IF studies by biochemical fractionation experiments: In order to further support their IF studies the authors should include the WB analysis of nuclear/cytoplasmic fractionations for the following figures: (i) Figure 1D -this is very important and should also include the analysis of S127-P (ii) Figure 2B -to complement the analysis of Figure 1D (iii) Figure 3B -to fully establish the importance of NLK (iv) Figure 4H -it would be really important to back up the IF pictures, to fully establish that S128D is a mainly nuclear form irrespective of the conditions. 5) Define the Ser127 phosphorylation status of S128A and S128D tested in Figure 4 . Considering the very striking IF results shown in Figure 4H , it would be important to also define the Ser127 phosphorylation status of the S128A and S128D mutants of YAP by immunoblotting. Does S127-P negatively correlate with the nuclear localisation of S128D? 6) Re-label and expand Figure 5 : Considering that Figure 5 is the main figure regarding the biological relevance of the Ser128 phosphorylation of YAP, I think that this figure needs to be improved.
(i) First of all, all three experiments needed to be presented as n=3 with a corresponding statistical analysis of differences.
(ii) The labelling in Figure 5B needs to be adjusted. Instead of "apoptotic" it should state "cell death" or "sub-G1", since this analysis does not allow any conclusion regarding the nature of the cell death as currently is implicated by the labelling. (iii) And most importantly (and quite essential), the experiments shown in Figure 5 that are comparing cells expressing YAP WT, S128A or S128D need to be compared to their proper control, which are empty vector expressing cells. -How much proliferation decrease/cell death/apoptosis is altered in cells expressing empty vector alone without any overexpression of any YAP variant? 7) Question regarding the in vitro kinase assay (as described in the Methods section): Why did the authors use mild lysis buffer conditions to measure the activities of Lats1 and NLK? Would it not be better to use stringent buffer conditions to be sure that you are only measuring the kinase at hand and not any potentially co-immunoprecipitating kinase (that it more likely to co-complex in mild conditions than under stringent conditions)?
Minor points:
A) Please add page numbers. B) Add references/text in introduction section: In order to give the non-expert reader a little bit more information in the introduction section, Hong et al. should: (i) Extend a little bit more on S127 related literature In order to give a broader picture regarding the role of S127 phosphorylation of YAP, I think that the authors should also mention and reference the following key publication: (iii) Describe briefly the S127 and S381 (S397) phosphorylation of YAP as regulatory mechanisms (including some key references).
The manuscript by Hong et al outlines a mechanism by which osmotic stress, which can be induced by the introduction of high levels of Sorbitol or NaCl in cell growth media, induces the nuclear localization and activity of the Hippo pathway effectors YAP and TAZ. The authors describe a mechanism by which phosphorylation of YAP on Ser128 upon osmotic stress increases nuclear YAP localization and activity. Ser128 lies adjacent to the well characterized Ser127 within YAP, which is phosphorylated in response to Hippo pathway activity and controls YAP binding to 14-3-3, which is a major mechanism thought to induce YAP cytoplasmic restriction. The authors propose that phosphorylation of S128 disrupts 14-3-3 binding and thereby increase nuclear YAP. The authors also suggest that NLK is the kinase that mediates YAP-S128 phosphorylation in response to osmotic stress, and provide evidence that mutation of Ser128 within YAP leads to increased nuclear YAP activity. The manuscript outlines a new biological mechanism for YAP/TAZ regulation and identifies a novel kinase that controls YAP activity, which together make this manuscript conceptually interesting. However, several things need to be addressed before the data is suitable for publication, most of which are outlined below: 1) -The proposed mechanism of osmotic stress regulating YAP/TAZ phosphorylation/activity is inconsistent with the data published by the same group. A previous publication from the Guan Lab (Mo et al, 2015) Supplemental Figure S1 shows 25mM and 50mM Sorbitol shows no changes in YAP phosphorylation, which contradicts the data presented in Fig1A 2) -Osmotic stress has long been known to impact actin cytoskeleton remodeling, and therefore given the relationship between actin regulation and YAP/TAZ localization it is possible that changes in the actin cytoskeleton mediate the observed changes described by the authors. The authors should determine how the concentrations of Sorbitol and NaCl impact the actin cytoskeleton in the cells that they are using, and determine whether these potential changes impact YAP/TAZ. It would also be very interesting to examine whether NLK-mediated phosphorylation of YAP/TAZ is regulated by actin changes.
3) -Quantitation of all the presented immunofluorescence experiments need to be included.
4) -The authors should show by biochemical fractionation that nuclear YAP localization is induced by osmotic stress. Also, the authors should provide evidence by IF or by nuclear/cytoplasmic fractionation that pYAP-S127 (and pYAP-S128) is present in the nucleus, which would be expected based on the data presented. Fig 4C showing the effects on YAP-p-S128 by Sorbitol is interesting, but it is unclear why endogenous YAP was not examined. This regulation (ideally with endogenous YAP) should also be shown in another cell type (e.g. MCF10A cells used in Fig EV1A) . It would also be prudent to show levels of NLK during this treatment. Is NLK more active or is there more NLK in the cells that cause this response? 6) -A comment about the decreased interaction between 14-3-3 and YAP upon prolonged Sorbitol treatment in Fig 1G should be made. Also, YAP p-S127 levels should be measured in parallel, particularly if they want to conclude "YAP-14-3-3 binding was not increased upon sorbitol treatment despite YAP Ser127 phosphorylation". Similar analysis of YAP p-S127 should also be performed in Fig 2E. 7) -The experiment in Fig 2D should be conducted in parallel with YAP/TAZ knockdown to show that the sorbitol induced expression of CTGF and CYR61 is dependent on YAP/TAZ. This is a critical control for proper conclusions to made from this experiment. 8) -An important control for the kinase assay presented in Fig 3E is the inclusion of GST alone control to determine whether NLK can non-discriminately phosphorylate the GST fusion on YAP. Additionally, a S128A mutant of YAP should be tested in the kinase assay to show that this residue is indeed the target of NLK. 9) -It is curious that there is a shift in the mobility of the YAP S128A mutant in the presence of NLK in Fig 4A. Does this indicate that NLK phosphorylates YAP on residue(s) beyond S128? 10) -Throughout the manuscript the authors state that the kinase assays that are used show direct phosphorylation of the substrate by the immunoprecipitated kinases. Statements regarding the ability for the kinase to directly phosphorylate the substrate cannot be made from immunoprecipitation experiments from mammalian cell lysates as it is possible that another kinase is co-precipitated in the experiments. Accordingly, the word "direct" should be removed from the manuscript text. If the authors want to make conclusions about direct phosphorylation the kinases should be purified using other systems. 14) -Many of the experiments throughout the paper use different cell lines, switching between HEK-293 and other cells with no justification for switching between the different experiments. Also, no information on whether NLK is expressed and to what these levels this might be between the the different cell types.
5) -The data in
1) Hong and colleagues present a manuscript that claims that NLK phosphorylates and activate YAP downstream of osmotic stress. They show that NLK phosphorylates YAP S128 and that this event promotes YAP activity. The analogous residue in Yorkie was shown many years ago by Irvine laboratory to positively regulate Yorkie activity. They showed this using in vivo experiments in flies but unfortunately this important study is not referenced.
2) The current manuscript uses many different cell culture and biochemical studies and for the most part these are thorough and well controlled. The main unresolved issue is: what is the role of NLK and osmotic stress in the regulation of YAP/Hippo in vivo. This is not explored.
3) Furthermore, there is no description of whether S128-YAP phosphorylation normally occurs in cells. Does it happen and the antibody simply can't detect it on endogenous YAP or does it not normally happen? 4) Lastly, the rationale on how they decided to pursue NLK and YAP-S128 are not clear or convincing? This weakens the study. 6) The figure legends are very wordy and read more like a blend of results/methods. 7) Several parts of the text are not clear. For example: "We found that expression of these two genes was not decreased (actually modestly increased) 4 hours after sorbitol treatment ( Fig 1E) ." If the statistical analysis found no significant change then is not increased, modestly or otherwise.
8) "YAP nuclear localization was determined in the NLK KO cell pool. YAP nuclear translocation by osmotic stress was blocked in some cells, which presumably had NLK KO, but not other cells, which presumably had the wild-type NLK ( Fig 3B) ." This is unsatisfactory. Many other explanations are possible. This should be resolved, e.g. with NEK co-staining or by making clones of NEK CRISPR-treated cells that are verified as NEK mutant. 9) They state that when searching for NLK phosphorylation sites in YAP that "We checked YAP amino acids sequence and noticed that YAP Ser 128, which is adjacent to the Ser 127 site, is followed by a proline residue." In fact there are at least 6 "SP" clusters in YAP. What about the other ones? Why was S128 pursued? From the paper, it sounds more like they found out from Moon et al., what the site was and pursued it.
10) "Result showed that NLK expression indeed induced Ser 128 phosphorylation of WT YAP, and this phosphorylation was abolished in YAP S128A mutant ( Fig 4A) ." This isn't accurate -there is still a band. Is there another YAP-S128 kinase in addition to NLK? 11) 4C and 4D are not very convincing and should be quantified across multiple experiments. Referee #1:
We appreciate the referee for the positive opinion of our study and constructive suggestions.
Hong et al. report in this very interesting manuscript several points that are important for the broader Hippo signalling community. This manuscript is well-presented and the overall implications of the research findings have great potential. However, I think that this manuscript can benefit from some adjustments/extensions as outlined below. I firmly believe that by addressing these points this manuscript will be even more appreciated by the Hippo signalling community and the scientific community at large. 2) Include statistical analyses to support all "significant" statements. The authors repeatedly state that they observed "significant" changes, which consequently should be backed up by the statistical evaluation of at least three independent experiments. Fortunately, this should be rather easy for Moon et al. to address, since they state in the Methods section (in the subsection "Statistical analysis") that: "Each experiment was repeated three times..." Therefore, please include a statistical analysis of the three independent experiments for: (i) Figure 1C (change of Lats1 kinase activity) (ii) Figure 2E (change of 14-3-3/YAP interaction) (iii) Figure 4D (S128-P in NLK null vs. wild-type cells) (iv) Figure 4F (change of 14-3-3/YAP interaction) -to match/complement Figure 2E Figure 1C , 2E, 4D, and 4F. Student's t-tests were used (two-sided, n = 3) to determine the statistical significance.
Quantifications of Western Blot results are included in
3) Expand IF studies by biochemical fractionation experiments. In order to further support their IF studies the authors should include the WB analysis of nuclear/cytoplasmic fractionations for the following figures: (i) Figure 1D -this is very important and should also include the analysis of S127-P (ii) Figure 2B -to complement the analysis of Figure 1D (iii) Figure 3B -to fully establish the importance of NLK Figure EV3D . We are assuming for (ii) the reviewer is asking for Figure 2A , which is YAP localization in no serum condition. If the reviewer is asking for Figure 2B, (Data not included in the Peer Review Process File) (iv) Figure 4H -it would be really important to back up the IF pictures, to fully establish that S128D is a mainly nuclear form irrespective of the conditions.
We thank the reviewer for suggesting the fractionation experiments. For point (i), (ii), and (iii), subcellular fractionation experiments were performed and the data are included in
We performed the fractionation and the result is included in Figure EV4D . Consistent with the IF result, sorbitol did not increase nuclear YAP S128A or S128D mutant. However, likely due to the leakage of nuclear YAP during fractionation, the majority of YAP protein, regardless of WT or mutants, was recovered in the cytoplasmic fraction. Figure 4B : According to Figure 4A , the anti-Ser128-P antibody is specific. However, in Figure 4B 5) Define the Ser127 phosphorylation status of S128A and S128D tested in Figure 4 . Considering the very striking IF results shown in Figure 4H , it would be important to also define the Ser127 phosphorylation status of the S128A and S128D mutants of YAP by immunoblotting. Does S127-P negatively correlate with the nuclear localisation of S128D?
4) Explain the result shown in
We performed YAP S127 phosphorylation Western blot and found that Sorbitol induced YAP S127 phosphorylation in both the YAP S128A and YAP S128D mutant in the presence of serum, which had low basal YAP S127 phosphorylation. YAP localization does not correlate with S127 phosphorylation in the presence of osmotic stress. This is consistent with our model that S128 phosphorylation (mimicked by S128D mutation) is overriding the S127 regulation on YAP localization by interfering 14-3-3 binding. The new data is included at figure EV4E.
6) Re-label and expand Figure 5 . Considering that Figure 5 is the main figure regarding the biological relevance of the Ser128 phosphorylation of YAP, I think that this figure needs to be improved.
We thank the reviewer's suggestion. We have included the statistical analyses in Figure 5B and 5C. In both cases, YAP S128D mutant has lower Sub-G1 phase and apoptotic cells (double positives for 7-AAD and Annexin V) compared with S128A mutant after sorbitol treatment. Student's t-tests were used (two-sided, n = 3).
(ii) The labelling in Figure 5B needs to be adjusted. Instead of "apoptotic" it should state "cell death" or "sub-G1", since this analysis does not allow any conclusion regarding the nature of the cell death as currently is implicated by the labelling.
Labeling has been adjusted accordingly.
(iii) And most importantly (and quite essential), the experiments shown in Figure 5 that are comparing cells expressing YAP WT, S128A or S128D need to be compared to their proper control, which are empty vector expressing cells. (iii) Describe briefly the S127 and S381 (S397) phosphorylation of YAP as regulatory mechanisms (including some key references).
Revisions have been made to address each of the above points.

Referee #2:
The manuscript by Hong et al outlines a mechanism by which osmotic stress, which can be induced by the introduction of high levels of Sorbitol or NaCl in cell growth media, induces the nuclear localization and activity of the Hippo pathway effectors YAP and TAZ. The authors describe a mechanism by which phosphorylation of YAP on Ser128 upon osmotic stress increases nuclear YAP localization and activity. Ser128 lies adjacent to the well characterized Ser127 within YAP, which is phosphorylated in response to Hippo pathway activity and controls YAP binding to 14-3-3, which is a major mechanism thought to induce YAP cytoplasmic restriction. The authors propose that phosphorylation of S128 disrupts 14-3-3 binding and thereby increase nuclear YAP. The authors also suggest that NLK is the kinase that mediates YAP-S128 phosphorylation in response to osmotic stress, and provide evidence that mutation of Ser128 within YAP leads to increased nuclear YAP activity. The manuscript outlines a new biological mechanism for YAP/TAZ regulation and identifies a novel kinase that controls YAP activity, which together make this manuscript conceptually interesting. However, several things need to be addressed before the data is suitable for publication, most of which are outlined below:
1 -The proposed mechanism of osmotic stress regulating YAP/TAZ phosphorylation/activity is inconsistent with the data published by the same group. A previous publication from the Guan Lab (Mo et al, 2015) Supplemental Figure S1 shows 25mM and 50mM Sorbitol shows no changes in YAP phosphorylation, which contradicts the data presented in Fig1A figure EV1A .
2) -Osmotic stress has long been known to impact actin cytoskeleton remodeling, and therefore given the relationship between actin regulation and YAP/TAZ localization it is possible that changes in the actin cytoskeleton mediate the observed changes described by the authors. The authors should determine how the concentrations of Sorbitol and NaCl impact the actin cytoskeleton in the cells that they are using, and determine whether these potential changes impact YAP/TAZ. It would also be very interesting to examine whether NLK-mediated phosphorylation of YAP/TAZ is regulated by actin changes.
We thank the reviewer for the comments, but feel that this may be beyond the scope of the current study. We have revised the manuscript to discuss this point in the discussion section.
IF quantifications are added in the figures.
4) -The authors should show by biochemical fractionation that nuclear YAP localization is induced by osmotic stress. Also, the authors should provide evidence by IF or by nuclear/cytoplasmic fractionation that pYAP-S127 (and pYAP-S128) is present in the nucleus, which would be expected based on the data presented. Figure EV3D . 5) -The data in Fig 4C showing the effects on YAP-p-S128 by Sorbitol is interesting, but it is unclear why endogenous YAP was not examined. This regulation (ideally with endogenous YAP) should also be shown in another cell type (e.g. MCF10A cells used in Fig EV1A) . It would also be prudent to show levels of NLK during this treatment. Is NLK more active or is there more NLK in the cells that cause this response?
We thank the reviewer for suggesting the fractionation experiments. Subcellular fractionation experiments were performed and the data are included in
Actually, S128 phosphorylation of immunoprecipitated endogenous YAP was presented in the original figure. We are sorry that the figure was not clearly labeled. We have rearranged the figure to make it clear regarding the data from endogenous YAP and transfected Flag-YAP (Fig.4C) Figure EV4B ). NLK level is unchanged upon osmotic stress treatment (shown below), but its activity has been shown to be induced by osmotic stress in our previous study [1] .
(Data not included in the Peer Review Process File)
6) -A comment about the decreased interaction between 14-3-3 and YAP upon prolonged Sorbitol treatment in Fig 1G should be made. Also, YAP p-S127 levels should be measured in parallel, particularly if they want to conclude "YAP-14-3-3 binding was not increased upon sorbitol treatment despite YAP Ser127 phosphorylation". Similar analysis of YAP p-S127 should also be performed in Fig 2E . Fig 1A. (Data not included in the Peer Review Process File) 7) -The experiment in Fig 2D should be conducted in parallel with YAP/TAZ knockdown to show that the sorbitol induced expression of CTGF and CYR61 is dependent on YAP/TAZ. This is a critical control for proper conclusions to made from this experiment. Fig 3E is the inclusion of GST alone control to determine whether NLK can non-discriminately phosphorylate the GST fusion on YAP. Additionally, a S128A mutant of YAP should be tested in the kinase assay to show that this residue is indeed the target of NLK. Figure 4A and 4B have shown that YAP Ser 128 is an NLK target site both in vitro and in vivo.
We have commented the decreased YAP and 14-3-3 interaction in the revised manuscript. We examined YAP Ser 127 phosphorylation status under these experimental conditions. As expected, YAP S127 phosphorylation was increased. The data is included for reviewer's information, but not added to the manuscript because the same point of increased YAP S127 phosphorylation by osmotic stress is shown in
We have performed the experiments with the YAP/TAZ dKO cells as controls. Our result shows that CTGF and Cyr61 expression can only be induced in WT cells but not the YAP/TAZ dKO cells (twosided student's t-test, n = 3) (Figure 2D), suggesting that the induction of CTGF and Cyr61 by sorbitol is YAP/TAZ dependent.
8) -An important control for the kinase assay presented in
According to the reviewer's suggestion, we have included GST alone as a control to make sure NLK phosphorylates YAP protein but not GST. Our result (see attached below) shows that GST was not phosphorylated by NLK (left panels). We have also tried in vitro kinase assay using GST-YAP S128A mutation. GST-YAP S128A mutant could still be phosphorylated by NLK (see attached below, right panels), suggesting that NLK can phosphorylate YAP on additional sites. This result is expected because YAP has 10 putative NLK phosphorylation consensus sites SP or TP. The data in
(Data not included in the Peer Review Process File) 9) -It is curious that there is a shift in the mobility of the YAP S128A mutant in the presence of NLK in Fig 4A. Does this indicate that NLK phosphorylates YAP on residue(s) beyond S128?
Consistent with the reviewer's suggestion that besides S128, NLK can phosphorylate YAP on additional residues (see response to question 8). We noted this point in the revised manuscript.
10) -Throughout the manuscript the authors state that the kinase assays that are used show direct phosphorylation of the substrate by the immunoprecipitated kinases. Statements regarding the ability of the kinase to directly phosphorylate the substrate cannot be made from immunoprecipitation experiments from mammalian cell lysates as it is possible that another kinase is co-precipitated in the experiments. Accordingly, the word "direct" should be removed from the manuscript text. If the authors want to make conclusions about direct phosphorylation the kinases should be purified using other systems. 12) -A control for non-specific binding is missing in Fig 4F. The experiment should be repeated with Flag-YAP and Flag-YAP-S128A expressed without Myc-14-3-3.
We apologize for the insufficient control in this experiment. We have presented data including the control of without Myc-14-3-3 ( Figure 4F ).
13) -The expression of YAP target genes should be tested from the cells used in Fig 5 in the presence and absence of osmotic stress.
We thank for the reviewer's suggestion. But we feel this information is not necessary for the conclusion of the figure that S128 phosphorylation affects YAP localization.
14) -Many of the experiments throughout the paper use different cell lines, switching between HEK-293 and other cells with no justification for switching between the different experiments. Also, no information on whether NLK is expressed and to what these levels this might be between the different cell types.
We have mostly used HEK293A cells in our study (virtually for all experiments). We also used MCF10A to support the idea that this regulation is not restricted to HEK293A cells only. NLK levels in HEK293A and MCF10A cells are similar (see the attachment in response to comment #5). Based on the protein atlas database, NLK is widely expressed in many cell types.
Referee #3:
1)
Hong and colleagues present a manuscript that claims that NLK phosphorylates and activate YAP downstream of osmotic stress. They show that NLK phosphorylates YAP S128 and that this event promotes YAP activity. The analogous residue in Yorkie was shown many years ago by Irvine laboratory to positively regulate Yorkie activity. They showed this using in vivo experiments in flies but unfortunately this important study is not referenced.
We thank the reviewer for the insightful comment. We have discussed the drosophila study and cited the reference, which is consistent with our study, in the revised discussion section.
2) The current manuscript uses many different cell culture and biochemical studies and for the most part these are thorough and well controlled. 3) Furthermore, there is no description of whether S128-YAP phosphorylation normally occurs in cells. Does it happen and the antibody simply can't detect it on endogenous YAP or does it not normally happen?
We showed in Figure 4C that osmotic stress increased S128 phosphorylation of endogenous YAP. We apologize that the original figure 4C was not clearly labeled. We have rearranged the figure to make the endogenous YAP S128 phosphorylation data obvious. In addition, according to the online database phosphosite.org website, YAP S128 phosphorylation has been detected by many phosphoproteomic studies. Thus, YAP S128 is likely to be phosphorylated in vivo.
4) Lastly, the rationale on how they decided to pursue NLK and YAP-S128 are not clear or convincing. This weakens the study. (Fig EV3D) .
6) The figure legends are very wordy and read more like a blend of results/methods.
We apologize for the poor wording in the figure legends. We have revised the figure legends to make them more concise.
7) Several parts of the text are not clear. For example: "We found that expression of these two genes was not decreased (actually modestly increased) 4 hours after sorbitol treatment (Fig 1E) ." If the statistical analysis found no significant change then is not increased, modestly or otherwise. Thank you for the submission of your revised manuscript to our editorial offices. We have now received the three referee reports that you will find enclosed below. As you will see, all three referees support the publication of your manuscript in EMBO reports. However, before we can proceed with formal acceptance, I have a few editorial requests.
Your manuscript has currently 5 figures and 4 EV figures. However, figures 4 and 5 have are currently multi-page format, which does not fit to the requirements of our publisher. Please prepare the figure files according to these guidelines and upload these as single high-resolution files in TIFF or EPS format.
For a scientific report we only allow 5 figures and the results and discussion sections must be combined. If you whish to publish this as scientific report, then you need to fit your data into 5 single page figures and not more than 5 EV figures. Additional data could be shown in an Appendix (see below). Otherwise, I suggest publishing this as an article.
Supplementary/additional data: The Expanded View format, which will be displayed in the main HTML of the paper in a collapsible format, has replaced the Supplementary information. You can submit up to 5 images as Expanded View. Please follow the nomenclature Figure EV1 , Figure EV2 etc. The figure legend for these should be included in the main manuscript document file in a section called Expanded View Figure Please update all the call-outs in the manuscript when you change the figures! Please also provide a legend for Figure EV4E .
The scale bars in the microscopic images differ in thickness. Please provide clear to see scale bars of similar thickness for these panels.
REFEREE REPORTS ------------------------------------------------Referee #1:
The authors have sufficiently addressed all my concerns by significantly expanding the originally manuscript by responding to nearly all of my points experimentally.
------------------------------------------------Referee #2:
This revised manuscript by Hong et al. is much improved and the authors have addressed most of my concerns. The manuscript is suitable for publication.
------------------------------------------------Referee #3:
The in vivo significance of YAP-S128 phosphorylation by NLK has not been tested and is still
Data
the data were obtained and processed according to the field's best practice and are presented to reflect the results of the experiments in an accurate and unbiased manner. figure panels include only data points, measurements or observations that can be compared to each other in a scientifically meaningful way. graphs include clearly labeled error bars for independent experiments and sample sizes. Unless justified, error bars should not be shown for technical replicates. if n< 5, the individual data points from each experiment should be plotted and any statistical test employed should be justified
Please fill out these boxes ê (Do not worry if you cannot see all your text once you press return) a specification of the experimental system investigated (eg cell line, species name).
C-Reagents
D-Animal Models E-Human Subjects
B-Statistics and general methods
the assay(s) and method(s) used to carry out the reported observations and measurements an explicit mention of the biological and chemical entity(ies) that are being measured. an explicit mention of the biological and chemical entity(ies) that are altered/varied/perturbed in a controlled manner.
the exact sample size (n) for each experimental group/condition, given as a number, not a range; a description of the sample collection allowing the reader to understand whether the samples represent technical or biological replicates (including how many animals, litters, cultures, etc.).
Each figure caption should contain the following information, for each panel where they are relevant:
Captions
The data shown in figures should satisfy the following conditions:
Source Data should be included to report the data underlying graphs. Please follow the guidelines set out in the author ship guidelines on Data Presentation.
a statement of how many times the experiment shown was independently replicated in the laboratory.
Any descriptions too long for the figure legend should be included in the methods section and/or with the source data.
Please ensure that the answers to the following questions are reported in the manuscript itself. We encourage you to include a specific subsection in the methods section for statistics, reagents, animal models and human subjects. This checklist is used to ensure good reporting standards and to improve the reproducibility of published results. These guidelines are consistent with the Principles and Guidelines for Reporting Preclinical Research issued by the NIH in 2014. Please follow the journal's authorship guidelines in preparing your manuscript.
